- Home
- NEGG vs NBTX Comparison
NEGG vs NBTX Comparison
Compare NEGG & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEGG | NBTX |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | France |
| Employees | 762 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.1M | 1.0B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NEGG | NBTX |
|---|---|---|
| Price | $44.32 | $36.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $26.00 |
| AVG Volume (30 Days) | ★ 43.3K | 28.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $2.95 |
| 52 Week High | $137.84 | $33.80 |
Technical Indicators
Market Signals| Indicator | NEGG | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 77.98 |
| Support Level | $42.81 | $20.11 |
| Resistance Level | $56.73 | N/A |
| Average True Range (ATR) | 3.35 | 1.77 |
| MACD | -0.62 | 0.95 |
| Stochastic Oscillator | 27.95 | 97.66 |
Price Performance
Historical ComparisonAbout NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.